IllumiNeuro Protocol (IllumiNeuro)
Four-Peptide Cognitive Enhancement Blend
Overview
IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination.
Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.
Combined BDNF support and neuritogenic effects may enhance memory formation and learning.
NA-Semax component supports sustained attention and mental clarity.
Multiple pathways protecting neural tissue from oxidative stress and damage.
NA-Selank provides anxiolytic effects through GABA modulation.
Mechanism
IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination.
Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.
Combined BDNF support and neuritogenic effects may enhance memory formation and learning.
Research areas
- IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination.
- Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.
- Combined BDNF support and neuritogenic effects may enhance memory formation and learning.
- NA-Semax component supports sustained attention and mental clarity.
- Multiple pathways protecting neural tissue from oxidative stress and damage.
- NA-Selank provides anxiolytic effects through GABA modulation.
- Immune-neuroendocrine support helps with stress resilience.
- Combined effects on neurotransmitter systems may improve overall mood.
- PE-22-28 promotes neural connectivity and neurite extension.
- Pinealon supports healthy sleep-wake cycles and pineal function.
Research notes
- Injection site reactions (mild)
- Nasal irritation if used intranasally
- Possible vivid dreams (Pinealon effect)
- Mild headache initially
- Severe headaches
- Significant mood changes
- Allergic reactions
- Cognitive impairment instead of enhancement
- No clinical trials on four-peptide combination
- Bipolar disorder or psychosis (caution with cognitive enhancers)
- Pregnancy or breastfeeding
- Seizure disorders (theoretical concern)
FAQs
What's in IllumiNeuro and why is it a blend?
IllumiNeuro combines four neuroactive peptides: PE-22-28 (neurite growth), Pinealon (pineal/circadian support), NA-Semax (BDNF/neuroprotection), and NA-Selank (anxiety relief). The blend targets multiple cognitive pathways simultaneously for theoretically broader benefits than any single peptide.
Can I take IllumiNeuro separately or must I use the blend?
You can take individual components separately, but do NOT add extra NA-Semax or NA-Selank to the blend—they're already included. The standard 48mg vial contains all four at fixed ratios: PE-22-28 10mg, Pinealon 10mg, NA-Semax 20mg, NA-Selank 8mg.
Does IllumiNeuro work for anxiety specifically?
The NA-Selank component has documented anxiolytic effects via GABA modulation. However, no clinical studies exist on this four-peptide combination. Individual peptides show promise for anxiety in research, but human efficacy data is limited.
Should I inject IllumiNeuro in the morning or evening?
Morning dosing is preferred for cognitive benefits during the day. Pinealon's sleep-supporting properties might suggest evening, but most users report better focus and mental clarity when dosed in the morning on an empty stomach.